GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » E10

HLB Therapeutics Co (XKRX:115450) E10 : ₩-166.12 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

HLB Therapeutics Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩2.126. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩-166.12 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 27.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of HLB Therapeutics Co was 27.00% per year. The lowest was 20.00% per year. And the median was 23.50% per year.

As of today (2024-05-26), HLB Therapeutics Co's current stock price is ₩8190.00. HLB Therapeutics Co's E10 for the quarter that ended in Mar. 2024 was ₩-166.12. HLB Therapeutics Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of HLB Therapeutics Co was 2.31. The lowest was 0.00. And the median was 1.33.


HLB Therapeutics Co E10 Historical Data

The historical data trend for HLB Therapeutics Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co E10 Chart

HLB Therapeutics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -351.07 -427.90 -182.31 -179.49 -166.72

HLB Therapeutics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -184.30 -177.62 -176.69 -166.72 -166.12

Competitive Comparison of HLB Therapeutics Co's E10

For the Biotechnology subindustry, HLB Therapeutics Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Therapeutics Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Therapeutics Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where HLB Therapeutics Co's Shiller PE Ratio falls into.



HLB Therapeutics Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HLB Therapeutics Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.126/118.8477*118.8477
=2.126

Current CPI (Mar. 2024) = 118.8477.

HLB Therapeutics Co Quarterly Data

per share eps CPI Adj_EPS
201406 11.669 99.353 13.959
201409 -14.936 99.608 -17.821
201412 -33.538 99.098 -40.222
201503 -93.818 99.720 -111.814
201506 -20.537 100.050 -24.396
201509 -19.137 100.110 -22.719
201512 -27.072 100.220 -32.104
201603 -22.871 100.560 -27.030
201606 -18.670 100.790 -22.015
201609 -27.072 101.460 -31.711
201612 -42.475 101.560 -49.705
201703 -39.674 102.850 -45.845
201706 -14.936 102.610 -17.300
201709 -27.539 103.490 -31.626
201712 -20.071 102.990 -23.161
201803 -18.670 104.100 -21.315
201806 -15.403 104.130 -17.580
201809 198.371 105.650 223.151
201812 -70.480 104.350 -80.272
201903 -35.007 104.490 -39.817
201906 -47.609 104.880 -53.949
201909 -35.940 105.200 -40.603
201912 -205.372 105.120 -232.192
202003 -13.069 105.540 -14.717
202006 -129.758 104.870 -147.053
202009 -60.211 106.200 -67.382
202012 -110.154 105.765 -123.779
202103 -42.942 107.357 -47.538
202106 -108.287 107.579 -119.630
202109 -39.674 108.759 -43.354
202112 -106.887 109.676 -115.825
202203 -29.406 111.806 -31.258
202206 -14.003 114.083 -14.588
202209 -45.593 114.831 -47.188
202212 -96.969 115.200 -100.039
202303 -17.391 116.550 -17.734
202306 43.478 117.140 44.112
202309 -13.797 119.111 -13.766
202312 -57.459 118.848 -57.459
202403 2.126 118.848 2.126

Add all the adjusted EPS together and divide 10 will get our e10.


HLB Therapeutics Co  (XKRX:115450) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of HLB Therapeutics Co was 2.31. The lowest was 0.00. And the median was 1.33.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


HLB Therapeutics Co E10 Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Therapeutics Co (XKRX:115450) Business Description

Traded in Other Exchanges
N/A
Address
22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines